Browsing: urged all patients currently taking Oxbryta to make an appointment with their doctor and develop a plan for gradually tapering off the medication.
The pharmaceutical giant last week announced it would voluntarily withdraw its sickle cell disease therapy, Oxbryta, from worldwide markets — to the surprise of doctors, patients and investors.
